Judge Jesus Bernal ruled in federal court in California’s Central District against the FDA’s argument that a group of stem cell clinics called the Cell Surgical Network, led by Mark Berman and Elliot Lander, were selling unapproved drug products in the form of adipose or fat cell mixtures. See the ruling here.
